Category

Articles

hub and spoke model for rare and orphan drugs
Articles
June 18, 2020

Revealing 5 hidden truths about using a hub-and-spoke model for rare and orphan drugs

The hub-and-spoke approach has become a standard of drug commercialization. Having a network of patient…
Read More
gaining payer access for rare and orphan drugs
Articles
June 16, 2020

Debunking 6 Myths About Gaining Payer Access for Rare and Orphan Drugs

What works for large patient populations isn’t necessarily a good fit for those with rare…
Read More